The Ribo-seq protocol was modified according to a previous study using 2.5 × 106 cells or approximately 10 µg of RNA38 (link). After optimization, we lowered the input to 50 mouse oocytes. Fifty denuded mouse oocytes were lysed in Ribo-seq lysis buffer (1% Triton X-100, 20 mM Tris–HCl pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 100 µg/µL cycloheximide). The total DNA and RNA were digested by a mix of 1 U TURBO™ DNase (AM2239, Invitrogen), 0.02 U RNase A, and 0.8 U RNase T1 Cocktail (AM2286, Invitrogen) at 37 °C for 30 min. The digestion was terminated using SUPERase•In™ RNAase inhibitor (AM2696, Invitrogen). RNAs were purified using TRIzol (15596026, Invitrogen) in phasemaker tubes (A33248, Invitrogen), and the resulting RNAs were treated with T4 PNK (M0201S, NEB) to conduct end-repair. Ribosome-protected fragments (RPFs) were separated using 40% RNA PAGE-gel. Resulting 26‒40 nt bands were cut and minced using Squisher-Single (H1001, ZYMO) and soaked in recovery buffer (300 mM NaOAc pH 5.5, 1 mM EDTA, 0.25% v/v SDS, 10 mM MgCl2) overnight. The RPFs were recovered by isopropanol precipitation. Libraries were then constructed using a SMARTer® smRNA-Seq Kit for Illumina (635030, TAKARA). Finally, samples were quantified using the Bioanalyzer High-Sensitivity DNA assay (Agilent Technologies) and sequenced using the Novaseq 6000 platform.
Free full text: Click here